Posted on

Political Showdown Over Tylenol: Why is the White House Warning Pregnant Women About Autism Risk?

476779360 920414666930644 4793422687884970194 n

the staff of the Ridgewood blog

Trenton NJ, the debate over the safety of acetaminophen (commonly known as Tylenol) during pregnancy has exploded into a national political controversy. Following a push from the Trump administration, the FDA has initiated a process to change the labeling on Tylenol to suggest a possible link to autism and ADHD—a move that has drawn fierce backlash from leading medical groups and even led to a public break with federal guidance by the New Jersey Health Department.

Continue reading Political Showdown Over Tylenol: Why is the White House Warning Pregnant Women About Autism Risk?

Posted on

Urgent Update for Parents-to-Be: New Guidance Links Common Pain Reliever to Autism Risk

Autism Sign

the staff of the Ridgewood blog

Ridgewood NJ, new CDC guidelines suggest a possible link between a pregnant person’s use of acetaminophen and the development of autism. However, the FDA has not established a causal relationship. Leucovorin has also been approved as a possible treatment for autism symptoms.

Continue reading Urgent Update for Parents-to-Be: New Guidance Links Common Pain Reliever to Autism Risk

Posted on

Johnson & Johnson spin off Kenvue Consumer Brands Largest Initial Public Offering in More than a Year

20230504 123652 scaled

the staff of the Ridgewood blog

Summit NJ, Johnson & Johnson spun off its Kenvue consumer brands division on Thursday, raising the most cash from an initial public offering (IPO) in more than a year. Johnson & Johnson said it sold 172.8 million shares(opens in new tab) at $22 a pop in Kenvue, giving the company whose brands include Band-Aid, Tylenol and Listerine a valuation of roughly $40 billion.

Continue reading Johnson & Johnson spin off Kenvue Consumer Brands Largest Initial Public Offering in More than a Year